SCHEMBL5436840

SCHEMBL5436840

O=c1[nH]c2cc(C(F)(F)F)ccc2n1-c1cc(-c2ccc(OC(F)(F)F)cc2)c(O)cc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 12/20 0.64
MEN1 O00255 1/20 0.64
CYP1A2 P05177 1/20 0.64
CYP3A4 P08684 1/20 0.64
MAPT P10636 1/20 0.64
CYP2C9 P11712 1/20 0.64
TSHR P16473 1/20 0.64
NFKB1 P19838 1/20 0.64
CYP2C19 P33261 1/20 0.64
BLM P54132 1/20 0.64
PMP22 Q01453 1/20 0.64
KMT2A Q03164 1/20 0.64
KCNMA1 Q12791 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
HCRTR1 O43613 1/20 0.37
PDE5A O76074 1/20 0.36
PDE9A O76083 1/20 0.36
AKT2 P31751 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5438965 0.89 HSP90AA1 (0.60) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5427828 0.87 HSP90AA1 (0.69) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5434241 0.86 HSP90AA1 (0.67) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5443038 0.86 HSP90AA1 (0.67) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5438828 0.86 HSP90AA1 (0.70) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5431204 0.84 HSP90AA1 (0.64) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5439960 0.83 HSP90AA1 (0.69) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5434104 0.83 HSP90AA1 (0.62) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5434075 0.82 HSP90AA1 (0.67) HSP90AA1MEN1CYP1A2CYP3A4MAPT
SCHEMBL5438901 0.81 HSP90AA1 (0.60) HSP90AA1MEN1CYP1A2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771456-A2 HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT Palumed SA (FR) 2007-04-11 EP claimed
WO-2006024741-A2 HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT PALUMED S.A. (FR) 2006-03-09 WO claimed
US-20070105862-A1 Heat-shock protein binders ABBOTT LABORATORIES 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105862-A1 Heat-shock protein binders HSP90AB1, HSP90AB2P, HSP90B1 HSP90AA1 5/4885MEN1 4017/4885CYP1A2 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.